The future of BRS in bifurcations

Robin P. Kraak; Maik J. Grundeken; Yoshinobu Onuma; Shengxian Tu; Joanna J. Wykrzykowska; Bernard Chevalier; John Ormiston; Patrick W. Serruys

doi:https://doi.org/10.4244/EIJV11SVA45

The future of BRS in bifurcations

Robin P. Kraak, Maik J. Grundeken, Yoshinobu Onuma, Shengxian Tu, Joanna J. Wykrzykowska, Bernard Chevalier, John Ormiston, Patrick W. Serruys

Research output: Contribution to journal › Article › Academic › peer-review

10 Citations (Scopus)

Abstract

Bioresorbable scaffolds (BRS) provide a new tool for percutaneous treatment of coronary stenosis. Initially, relatively simple coronary artery lesions were treated with this novel technology; nowadays, we have gained more experience with a wide variety of lesions, including bifurcation lesions. Data are limited in terms of the use of BRS in coronary bifurcation lesions, although it has been demonstrated that over time the bioresorbable struts are replaced by a tissue bridge resembling a "neo-carina". Furthermore, data are emerging about the endothelial shear stress (ESS) alterations and blood flow patterns after scaffold implantation. It is likely that ESS and blood flow determinations will guide correct future bifurcation techniques. In the future, BRS with thinner struts and more resistant to fracture are likely to improve bifurcation treatment with BRS

Original language	English
Pages (from-to)	V188-V192
Journal	Eurointervention
Volume	11
Issue number	Suppl. V
DOIs	https://doi.org/10.4244/EIJV11SVA45
Publication status	Published - 2015

Access to Document

https://doi.org/10.4244/EIJV11SVA45

Cite this

@article{5621041f0b774d92a316b729677c15b1,

title = "The future of BRS in bifurcations",

abstract = "Bioresorbable scaffolds (BRS) provide a new tool for percutaneous treatment of coronary stenosis. Initially, relatively simple coronary artery lesions were treated with this novel technology; nowadays, we have gained more experience with a wide variety of lesions, including bifurcation lesions. Data are limited in terms of the use of BRS in coronary bifurcation lesions, although it has been demonstrated that over time the bioresorbable struts are replaced by a tissue bridge resembling a {"}neo-carina{"}. Furthermore, data are emerging about the endothelial shear stress (ESS) alterations and blood flow patterns after scaffold implantation. It is likely that ESS and blood flow determinations will guide correct future bifurcation techniques. In the future, BRS with thinner struts and more resistant to fracture are likely to improve bifurcation treatment with BRS",

author = "Kraak, {Robin P.} and Grundeken, {Maik J.} and Yoshinobu Onuma and Shengxian Tu and Wykrzykowska, {Joanna J.} and Bernard Chevalier and John Ormiston and Serruys, {Patrick W.}",

year = "2015",

doi = "https://doi.org/10.4244/EIJV11SVA45",

language = "English",

volume = "11",

pages = "V188--V192",

journal = "Eurointervention",

issn = "1774-024X",

publisher = "EuroPCR",

number = "Suppl. V",

}

TY - JOUR

T1 - The future of BRS in bifurcations

AU - Kraak, Robin P.

AU - Grundeken, Maik J.

AU - Onuma, Yoshinobu

AU - Tu, Shengxian

AU - Wykrzykowska, Joanna J.

AU - Chevalier, Bernard

AU - Ormiston, John

AU - Serruys, Patrick W.

PY - 2015

Y1 - 2015

N2 - Bioresorbable scaffolds (BRS) provide a new tool for percutaneous treatment of coronary stenosis. Initially, relatively simple coronary artery lesions were treated with this novel technology; nowadays, we have gained more experience with a wide variety of lesions, including bifurcation lesions. Data are limited in terms of the use of BRS in coronary bifurcation lesions, although it has been demonstrated that over time the bioresorbable struts are replaced by a tissue bridge resembling a "neo-carina". Furthermore, data are emerging about the endothelial shear stress (ESS) alterations and blood flow patterns after scaffold implantation. It is likely that ESS and blood flow determinations will guide correct future bifurcation techniques. In the future, BRS with thinner struts and more resistant to fracture are likely to improve bifurcation treatment with BRS

AB - Bioresorbable scaffolds (BRS) provide a new tool for percutaneous treatment of coronary stenosis. Initially, relatively simple coronary artery lesions were treated with this novel technology; nowadays, we have gained more experience with a wide variety of lesions, including bifurcation lesions. Data are limited in terms of the use of BRS in coronary bifurcation lesions, although it has been demonstrated that over time the bioresorbable struts are replaced by a tissue bridge resembling a "neo-carina". Furthermore, data are emerging about the endothelial shear stress (ESS) alterations and blood flow patterns after scaffold implantation. It is likely that ESS and blood flow determinations will guide correct future bifurcation techniques. In the future, BRS with thinner struts and more resistant to fracture are likely to improve bifurcation treatment with BRS

U2 - https://doi.org/10.4244/EIJV11SVA45

DO - https://doi.org/10.4244/EIJV11SVA45

M3 - Article

C2 - 25983164

SN - 1774-024X

VL - 11

SP - V188-V192

JO - Eurointervention

JF - Eurointervention

IS - Suppl. V

ER -